ADVANCED ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Clinical trials for ADVANCED ESOPHAGEAL SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED ESOPHAGEAL SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED ESOPHAGEAL SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New Two-Drug combo challenges standard care for tough esophageal cancer
Disease control Not yet recruitingThis study is comparing a new two-drug combination (anlotinib + benmelstobart) against the current standard treatment (toripalimab + chemotherapy) for people with advanced esophageal cancer that has specific gene changes. It aims to see if the new combination is safer and more ef…
Matched conditions: ADVANCED ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE3 • Sponsor: The First Affiliated Hospital of Zhengzhou University • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
New drug combo trial offers hope for Tough-to-Treat esophageal cancer
Disease control Not yet recruitingThis study aims to test the safety and early effectiveness of a new combination therapy called JS212 for adults with advanced esophageal cancer that has spread or returned. It will involve about 280 patients who have not received prior drug treatment for their advanced disease. T…
Matched conditions: ADVANCED ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Shanghai Junshi Bioscience Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC